hers semaglutide reddit The GLP-1 drug shortage is over. What's next for the compounders? - Pharma Technology Focus | Issue 154 Novo Nordisk drops its Hims

Angry patients spur new state watchdogs to bring down drug prices But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients starting body mass index, or BMI

Because so many people are using these medications its critical to monitor any ill effects on the eye or other parts of the body. For this investigative study, Katz and his team focused on nine patients with an average age of about 58, with five females and four males

Anyone considering these compounds should consult a healthcare professional and review the medical disclaimer

The results still havent been published

AK: Data curation, Formal Analysis, Investigation, Methodology, Validation, Writing review & editing